StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.37+0.01 (+0.05%)

Close on Nov 17, 2026Market cap $930.89MP/E –Yield –

Odyssey Therapeutics cash

Cash and short-term investments held at the end of each period.

Odyssey Therapeutics's cash was $310.58M at Jun 30, 2026. For fiscal 2025 it was $181.36M, up 190.9% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$181.36M+190.9%
FY2024Dec 31, 2024$62.35M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$310.58M+465.6%
Q1 FY2026Mar 31, 2026$175.75M+181.9%
Q4 FY2025Dec 31, 2025$181.36M–
Q2 FY2025Jun 30, 2025$163.00M–
Q1 FY2025Mar 31, 2025$54.91M–
Q4 FY2024Dec 31, 2024$62.35M–

More Odyssey Therapeutics figures

See a number that looks wrong?